
After analyzing preliminary data from 2006, indicating that fluoroquinolone-resistant gonorrhea is now widespread across the nation, the Centers for Disease Control and Prevention (CDC) is no longer recommending that the fluoroquinolone class of antibiotics be used to treat gonorrhea in the US.